Simplex Trading
ORKA

Simplex Trading’s Oruka Therapeutics ORKA Stock Holding History

Simplex Trading’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390K Buy
+4,100
New +$273K ﹤0.01% 3920
2026
Q1 		– Sell
-200
Closed -$6.06K – 10401
2025
Q4 		$6.06K Sell
200
-200
-50% -$5.57K ﹤0.01% 7320
2025
Q3 		$7K Buy
+400
New +$5.93K ﹤0.01% 8146
2025
Q2 		– Sell
-100
Closed -$1K – 9953
2025
Q1 		$1K Buy
+100
New +$1.25K ﹤0.01% 8348
2023
Q3 		– Sell
-108
Closed -$2K – 10056
2023
Q2 		$2K Sell
108
-1,184
-92% -$29.1K ﹤0.01% 8514
2023
Q1 		$30K Buy
+1,292
New +$34K ﹤0.01% 6501
2022
Q4 		– Sell
-233
Closed -$5K – 10673
2022
Q3 		$5K Sell
233
-667
-74% -$18.8K ﹤0.01% 8835
2022
Q2 		$26K Buy
900
+842
+1,452% +$23.8K ﹤0.01% 7314
2022
Q1 		$1K Buy
+58
New +$1.44K ﹤0.01% 10172
2021
Q4 		– Sell
-200
Closed -$8K – 11632
2021
Q3 		$8K Sell
200
-133
-40% -$4.92K ﹤0.01% 9079
2021
Q2 		$13K Buy
333
+329
+8,225% +$13.7K ﹤0.01% 8939
2021
Q1 		$17K Sell
4
-1
-20% -$52 ﹤0.01% 7599
2020
Q4 		$23K Buy
+5
New +$249 ﹤0.01% 6887

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Simplex Trading's ORKA Position: Q2 2026 in Review

Simplex Trading sold out of Oruka Therapeutics (ORKA) in Q2 2026, closing a stake of 2,463 shares — an estimated $164K sold.

Simplex Trading first reported a position in ORKA in Q4 2020 and held it in 10 quarters. The position peaked at $121K in Q1 2026. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Simplex Trading reported no remaining Oruka Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 2,463 Oruka Therapeutics shares in Q2 2026, an estimated $164K.
  • Simplex Trading first reported a position in Oruka Therapeutics in Q4 2020 and held it in 10 quarters.
  • Simplex Trading's Oruka Therapeutics position peaked at $121K in Q1 2026.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.